The government shutdown isn't stopping Food and Drug Administration advisory committee meetings scheduled this month, according to drug and device manufacturers.
Some analysts warned that the shutdown could limit the FDA's panel discussions, postpone meetings and ultimately delay product launches and spook investors.
Read more »
A scheduled House committee hearing on the Food and Drug Administration's progress toward implementing a federal law requiring it to develop a regulatory strategy for health information technology was postponed Thursday, as the government shutdown continued into its third day.
Dr. Jeffrey Shuren, director of the FDA's Center for Devices and Radiological Health, was scheduled to testify before the Health Subcommittee of the House Energy and Commerce Committee on the Food and Drug Administration Safety Innovation Act.
Read more »
A federally chartered special work group with representatives from three federal agencies has submitted its draft recommendations on establishing a regulatory framework for health IT.
Read more »
Dr. Paul Offit, the chief of the infectious diseases division of Children's Hospital of Philadelphia, skewered the mega-vitamin industry in an article in the Sunday New York Times.
Read more »
